Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New treatment option for Gaucher's disease patients in Germany

Jan. 20, 1999

Nitromethyl ketones from Merck KGaA protect against diabetic complications

Jan. 20, 1999

Long-term beneficial effects of orlistat reported in JAMA

Jan. 20, 1999

Takeda submits NDA for type II diabetes treatment

Jan. 19, 1999

Besins Iscovesco provides funds to speed development of Andractim

Jan. 19, 1999

Knoll's antiobesity drug Reductil approved in Germany

Jan. 19, 1999

New indication approved for Livial, a tissue-specific treatment for menopausal symptoms

Jan. 19, 1999

Cyanoenamines as potassium channel modulators

Jan. 19, 1999

Warner-Lambert updates U.S. status of Rezulin

Jan. 18, 1999

Novel antidiabetic agents in development at Novo Nordisk

Jan. 18, 1999

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...